Oncology

Researchers continue to focus on developing an 8-week treatment regimen for hepatitis C virus.

Patients with ovarian cancer often face complex burdens that go beyond just medication.

Mastectomy rates increased after actress Angelia Jolie announced her procedure.

National brand spending and new patient rates for hepatitis C virus dropped last year.

Mass spectrometry device rapidly identifies molecular profile of cancerous tissue.

Beth Wallace was always one to advocate for herself in different areas of her life, but when it came to her health, she left it to the doctors. Here, she discusses the importance of education and being your own advocate.

Consistency among caregivers can be an important factor for patients undergoing treatment for cancer.

Cancer patient Beth Wallace speaks about her support system and the impact they have made on her life.

The pharma giant will now focus on its PD-1 cancer immunotherapy Keytruda.

Top news of the day from across the health care landscape.

Top news of the day from across the healthcare landscape.

Beth Wallace discusses various treatments for leiomyosarcoma, including doxorubicin (Adriamycin), nicknamed the red devil.

Gadolinium-containing imaging agent could improve breast cancer survival.

Recent studies suggested that hepatitis C antiviral drugs may increase the risk of hepatocellular carcinoma.

In part 2, Beth Wallace describes the events leading up to her diagnosis with leiomyosarcoma.

Pertuzumab-based regimen shows promise treating adjuvant treatment of HER2-positive early breast cancer.

Genentech is seeking approval for Perjeta used in combination with trastuzumab and chemotherapy for adjuvant treatment of HER2-positive early breast cancer.

Consolidative radiation followed by chemotherapy could play a key role in future survival outcomes among patients with non-small cell lung cancer.

New findings suggest alterations in this process may trigger cancer progression.

Top news of the week from Specialty Pharmacy Times.

Top news of the day from across the health care landscape.

Abemaciclib treats adults with hormone receptor-positive, human epidemical growth factor receptor-negative advanced or metastatic breast cancer that progressed after endocrine therapy.

Verzenio can be administered as a stand-alone treatment to patients previously treated with endocrine therapy and chemotherapy.

Officials with the FDA have approved abemaciclib (Verzenio, Eli Lilly), for the treatment of adults with certain advanced or metastatic breast cancer.

Top news of the week from Specialty Pharmacy Times.

Introducing microbes to replace missing metabolites could reduce cancer risk, study suggests.

Women with the hepatitis C virus have fewer live births and face a higher risk of miscarriage, infertility, gestational diabetes and pre-eclampsia.

Many researchers are interested in looking at FDA-approved drugs that could potentially be repositioned for use in cancer treatment.

Physical activity and a whole grain-rich diet lowers colorectal cancer risk, whereas red meat increases the risk.

Exposure to carbon may not increase the risk of death among hardmetal workers.